• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

non-patient focus

  1. Way to go Uncle NO

    FDA ready to crack down as Novartis reveals manipulated Zolgensma data
    • anonymous
    • Thread
    • crooks dishonesty non-patient focus
    • Replies: 1
    • Forum: Novartis
Top Bottom
Back